{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:14:40Z","timestamp":1762503280234,"version":"build-2065373602"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T00:00:00Z","timestamp":1661299200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["1\/1\/19 \u2013 12\/31\/23","P30-CA008748"],"award-info":[{"award-number":["1\/1\/19 \u2013 12\/31\/23","P30-CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.ctro.2022.08.013","type":"journal-article","created":{"date-parts":[[2022,8,28]],"date-time":"2022-08-28T12:16:35Z","timestamp":1661688995000},"page":"71-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Outcomes and toxicities after proton partial breast radiotherapy for early stage, hormone receptor positive breast cancer: 3-Year results of a phase II multi-center trial"],"prefix":"10.1016","volume":"37","author":[{"given":"J. Isabelle","family":"Choi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiran","family":"Prabhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William F.","family":"Hartsell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd","family":"DeWees","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Sinesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rashmi K.","family":"Benda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oren","family":"Cahlon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew L.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ctro.2022.08.013_b0005","first-page":"7","article-title":"Cancer Statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"10.1016\/j.ctro.2022.08.013_b0010","first-page":"438","article-title":"Breast cancer statistics, 2019","volume":"69","author":"DeSantis","year":"2019","journal-title":"CA Cancer J Clin"},{"year":"2021","series-title":"Cancer Facts & Figures 2021","author":"American Cancer Society","key":"10.1016\/j.ctro.2022.08.013_b0015"},{"issue":"9804","key":"10.1016\/j.ctro.2022.08.013_b0020","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/S0140-6736(11)61629-2","volume":"378","author":"Early Breast Cancer Trialists\u2019 Collaborative Group","year":"2011","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.ctro.2022.08.013_b0025","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa022152","article-title":"Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy and lumpectomy plus irradiation for the treatment of invasive breast cancer","volume":"347","author":"Fisher","year":"2002","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ctro.2022.08.013_b0030","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa0906260","article-title":"Long-term results of hypofractionated radiation therapy for breast cancer","volume":"362","author":"Whelan","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ctro.2022.08.013_b0035","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/S0140-6736(08)60348-7","article-title":"The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial","volume":"371","author":"START Trialists' Group","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ctro.2022.08.013_b0040","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ijrobp.2005.11.027","article-title":"Phase II trial of brachytherapy alone after lumpectomy for select breast cancer: toxicity analysis of RTOG 95\u201316","volume":"65","author":"Kuske","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"13","key":"10.1016\/j.ctro.2022.08.013_b0045","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S1470-2045(13)70497-2","article-title":"Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomized controlled equivalence trial","volume":"14","author":"Veronesi","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctro.2022.08.013_b0050","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0140-6736(10)60837-9","article-title":"Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomized, non-inferiority phase 3 trial","volume":"376","author":"Vaidya","year":"2010","journal-title":"Lancet"},{"issue":"10015","key":"10.1016\/j.ctro.2022.08.013_b0055","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0140-6736(15)00471-7","volume":"387","author":"Strnad","year":"2016","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ctro.2022.08.013_b0060","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ejca.2014.12.013","article-title":"Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial","volume":"51","author":"Livi","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ctro.2022.08.013_b0065","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/S0140-6736(19)32514-0","article-title":"Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomized, phase 3, equivalence trial","volume":"394","author":"Vicini","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ctro.2022.08.013_b0070","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijrobp.2009.01.041","article-title":"Unacceptable cosmesis in a protocol investigation intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiation","volume":"76","author":"Jagsi","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10215","key":"10.1016\/j.ctro.2022.08.013_b0075","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1016\/S0140-6736(19)32515-2","article-title":"External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in site and node-negative breast cancer (RAPID): a randomized controlled trial","volume":"394","author":"Whelan","year":"2019","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ctro.2022.08.013_b0080","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.ijrobp.2006.04.025","article-title":"Dosimetric Comparison of Proton and Photon Three-Dimensional, Conformal, External Beam Accelerated Partial Breast Irradiation Techniques","volume":"65","author":"Kozak","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ctro.2022.08.013_b0085","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/PPO.0b013e318046354b","article-title":"A technique of partial breast irradiation utilizing proton beam radiotherapy: Comparison with conformal X-ray therapy","volume":"13","author":"Bush","year":"2007","journal-title":"Cancer J"},{"issue":"1","key":"10.1016\/j.ctro.2022.08.013_b0090","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.radonc.2008.09.027","article-title":"Dosimetric comparison of four different external beam partial breast irradiation techniques: Three-dimensional conformal radiotherapy, intensity modulated radiotherapy, helical tomotherapy, and proton beam therapy","volume":"90","author":"Moon","year":"2009","journal-title":"Radiother Oncol"},{"issue":"25","key":"10.1016\/j.ctro.2022.08.013_b0095","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1200\/JCO.2005.05.1037","article-title":"Late cardiac mortality and morbidity in early-stage breast cancer patients after breast conservation treatment","volume":"24","author":"Harris","year":"2006","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.ctro.2022.08.013_b0100","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa1209825","article-title":"Risk of ischemic heart disease in women after radiotherapy for breast cancer","volume":"368","author":"Darby","year":"2013","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.ctro.2022.08.013_b0105","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1200\/JCO.2016.72.0722","article-title":"Estimating the risks of breast cancer radiotherapy: evidence from modern radiation doses to the lungs and heart and from previous randomized trials","volume":"35","author":"Taylor","year":"2017","journal-title":"J Clin Oncol"},{"issue":"21","key":"10.1016\/j.ctro.2022.08.013_b0110","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1200\/JCO.2006.08.6595","article-title":"Coronary artery findings after left-sided compared with right-sided radiation treatment for early-stage breast cancer","volume":"25","author":"Correa","year":"2007","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ctro.2022.08.013_b0115","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1200\/JCO.2011.34.5900","article-title":"Distribution of coronary artery stenosis after radiation for breast cancer","volume":"30","author":"Nilsson","year":"2012","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2022.08.013_b0120","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/sj.bjc.6605435","article-title":"Second solid cancers after radiotherapy for breast cancer in SEER cancer registries","volume":"102","author":"Berrington de Gonzalez","year":"2010","journal-title":"Br J Cancer"},{"issue":"34","key":"10.1016\/j.ctro.2022.08.013_b0125","doi-asserted-by":"crossref","first-page":"5561","DOI":"10.1200\/JCO.2007.16.0192","article-title":"Roles of radiotherapy and chemotherapy in the development of contralateral breast cancer","volume":"26","author":"Hooning","year":"2008","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2022.08.013_b0130","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.radonc.2014.10.004","article-title":"Risk of second non-breast cancer after radiotherapy for breast cancer: a systematic review and meta-analysis of 762,468 patients","volume":"114","author":"Grantzau","year":"2015","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.ctro.2022.08.013_b0135","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.ijrobp.2006.06.041","article-title":"Accelerated Partial Breast Irradiation Using Proton Beams: Initial Clinical Experience","volume":"66","author":"Kozak","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.ctro.2022.08.013_b0140","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.ijrobp.2014.04.008","article-title":"Long-term Cosmetic Outcomes and Toxicities of Proton Beam Therapy Compared With Photon-Based 3-Dimensional Conformal Accelerated Partial-Breast Irradiation: A Phase 1 Trial","volume":"90","author":"Galland-Girodet","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ctro.2022.08.013_b0145","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.radonc.2013.06.008","article-title":"Phase II Trial of Proton Beam Accelerated Partial Breast Irradiation in Breast Cancer","volume":"108","author":"Chang","year":"2013","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.ctro.2022.08.013_b0150","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.clbc.2011.03.023","article-title":"Partial Breast Irradiation Delivered With Proton Beam: Results of a Phase II Trial","volume":"11","author":"Bush","year":"2011","journal-title":"Clin Breast Cancer"},{"issue":"3","key":"10.1016\/j.ctro.2022.08.013_b0155","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ijrobp.2014.05.1308","article-title":"Partial Breast Radiation Therapy With Proton Beam: 5-Year Results With Cosmetic Outcomes","volume":"90","author":"Bush","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ctro.2022.08.013_b0160","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ijrobp.2020.09.009","article-title":"Proton Accelerated Partial Breast Irradiation: Clinical Outcomes at a Planned Interim Analysis of a Prospective Phase 2 Trial","volume":"109","author":"Pasalic","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ctro.2022.08.013_b0165","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-019-1417-7","article-title":"3 fraction pencil-beam scanning proton accelerated partial breast irradiation: early provider and patient reported outcomes of a novel regimen","volume":"14","author":"Mutter","year":"2019","journal-title":"Radiat Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2022.08.013_b0170","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ijrobp.2016.01.055","article-title":"First Clinical Investigation of Cone Beam Computed Tomography and Deformable Registration for Adaptive Proton Therapy for Lung Cancer","volume":"95","author":"Veiga","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"10.1016\/j.ctro.2022.08.013_b0175","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1002\/1097-0142(20010615)91:12<2273::AID-CNCR1258>3.0.CO;2-1","article-title":"Form or function? Part 1. Subjective cosmetic and functional correlated of quality of life in women treated with breast-conserving surgical procedures and radiotherapy","volume":"91","author":"Stanton","year":"2001","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ctro.2022.08.013_b0180","doi-asserted-by":"crossref","DOI":"10.1186\/s12874-019-0806-9","article-title":"refining scores based on patient reported outcomes \u2013 statistical and medical perspectives","volume":"19","author":"Fei\u00dft","year":"2019","journal-title":"BMC Med Res Methodology"},{"issue":"3","key":"10.1016\/j.ctro.2022.08.013_b0185","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0360-3016(03)01574-8","article-title":"Advantage of protons compared to conventional X-ray or IMRT in the treatment of a pediatric patient with medulloblastoma","volume":"58","author":"St Clair","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ctro.2022.08.013_b0190","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ijrobp.2013.01.014","article-title":"Proton Beam Craniospinal Irradiation Reduces Acute Toxicity for Adults With Medulloblastoma","volume":"86","author":"Brown","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"10.1016\/j.ctro.2022.08.013_b0195","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S1470-2045(14)70268-2","article-title":"Charged particle therapy versus photon therapy for paranasal sinus and nasal cavity malignant diseases: a systematic review and meta-analysis","volume":"15","author":"Patel","year":"2014","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2022.08.013_b0200","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.radonc.2016.05.022","article-title":"Intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer - A case matched analysis","volume":"120","author":"Blanchard","year":"2016","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2022.08.013_b0205","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijrobp.2019.01.076","article-title":"Protons versus Photons for Unresectable Hepatocellular Carcinoma: Liver Decompensation and Overall Survival","volume":"105","author":"Sanford","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.ctro.2022.08.013_b0210","doi-asserted-by":"crossref","first-page":"999","DOI":"10.21037\/jgo.2019.08.03","article-title":"Proton beam therapy versus stereotactic body radiotherapy for hepatocellular carcinoma: practice patterns, outcomes, and the effect of biologically effective dose escalation","volume":"10","author":"Hasan","year":"2019","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.ctro.2022.08.013_b0215","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1200\/JCO.19.02503","article-title":"Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for Locally Advanced Esophgeal Cancer","volume":"38","author":"Lin","year":"2020","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2022.08.013_b0220","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijrobp.2016.10.001","article-title":"National Cancer Database Analysis of Proton Versus Photon Radiation Therapy in Non-Small Cell Lung Cancer","volume":"97","author":"Higgins","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"21","key":"10.1016\/j.ctro.2022.08.013_b0225","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1002\/cncr.30870","article-title":"Prospective study of proton-beam radiation therapy for limited-stage small cell lung cancer","volume":"123","author":"Rwigema","year":"2017","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ctro.2022.08.013_b0230","doi-asserted-by":"crossref","DOI":"10.1186\/1748-717X-8-71","article-title":"Proton radiotherapy for chest wall and regional lymphatic radiation; dose comparisons and treatment delivery","volume":"8","author":"MacDonald","year":"2013","journal-title":"Radiat Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2022.08.013_b0235","doi-asserted-by":"crossref","first-page":"119","DOI":"10.14319\/jpt.11.9","article-title":"A treatment planning comparison of volumetric modulated arc therapy and proton therapy for a sample of breast cancer patients treated with post-mastectomy radiotherapy","volume":"1","author":"Hernandez","year":"2015","journal-title":"J Proton Ther"},{"key":"10.1016\/j.ctro.2022.08.013_b0240","doi-asserted-by":"crossref","first-page":"827","DOI":"10.14338\/IJPT-14-00025.1","article-title":"Proton therapy for local-regionally advanced breast cancer maximized cardiac sparing","volume":"1","author":"Fagundes","year":"2015","journal-title":"Int J Particle Ther"},{"issue":"5","key":"10.1016\/j.ctro.2022.08.013_b0245","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.ijrobp.2010.04.052","article-title":"External-beam Accelerated Partial Breast Irradiation Using Multiple Proton Beam Configurations","volume":"80","author":"Wang","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ctro.2022.08.013_b0250","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijrobp.2014.01.005","article-title":"Decline of Cosmetic Outcomes Following Accelerated Partial Breast Irradiation Using Intensity-Modulated Radiation Therapy: Results of a Single-Institution Prospective Clinical Trial","volume":"89","author":"Liss","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.ctro.2022.08.013_b0255","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ijrobp.2012.06.052","article-title":"The Effect of Dose-Volume Parameters and Intrafraction Interval on Cosmetic Outcome and Toxicity After 3-Dimensional Conformal Accelerated Partial Breast Irradiation","volume":"85","author":"Leonard","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.ctro.2022.08.013_b0260","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/0360-3016(94)90312-3","article-title":"Dose and volume effects on fibrosis after breast conservation therapy","volume":"30","author":"Borger","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ctro.2022.08.013_b0265","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ijrobp.2017.04.022","article-title":"Predicted Rate of Secondary Malignancies Following Adjuvant Proton Versus Photon Radiation Therapy for Thymoma","volume":"99","author":"Vogel","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2022.08.013_b0270","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s41687-017-0008-3","article-title":"A systematic evaluation of compliance and reporting of patient-reported outcome endpoints in ovarian cancer randomized controlled trials: implications for generalizability and clinical practice","volume":"1","author":"Mercieca-Bebber","year":"2017","journal-title":"J Patient Rep Outcomes"},{"issue":"4","key":"10.1016\/j.ctro.2022.08.013_b0275","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.ijrobp.2010.01.059","article-title":"Reports of unexpected late side-effects of accelerated partial breast irradiation \u2013 radiobiological consideration","volume":"77","author":"Bentzen","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.ctro.2022.08.013_b0280","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.ijrobp.2019.02.050","article-title":"Daily Fractionation of External Beam Accelerated Partial Breast Irradiation to 40 Gy Is Well Tolerated and Locally Effective","volume":"104","author":"Braunstein","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2022.08.013_b0285","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0140-6736(20)30932-6","article-title":"Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomized, phase 3 trial","volume":"395","author":"Brunt","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ctro.2022.08.013_b0290","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0140-6736(17)31145-5","article-title":"Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomized, controlled, phase 3, non-inferiority trial","volume":"390","author":"Coles","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ctro.2022.08.013_b0295","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijrobp.2014.05.010","article-title":"Relative biological effectiveness variation along monoenergetic and modulated Bragg peaks of a 62-MeV therapeutic proton beam: a preclinical assessment","volume":"90","author":"Chaudhary","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ctro.2022.08.013_b0300","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.radonc.2005.03.006","article-title":"Economic evaluation of proton radiation therapy in the treatment of breast cancer","volume":"75","author":"Lundkvist","year":"2005","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.ctro.2022.08.013_b0305","doi-asserted-by":"crossref","DOI":"10.21037\/cco.2016.06.03","article-title":"Cost-comparativeness of proton versus photon therapy","volume":"5","author":"Verma","year":"2016","journal-title":"Chin Clin Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2022.08.013_b0310","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijrobp.2015.07.2285","article-title":"Proton Partial-Breast Irradiation for Early-Stage Cancer: Is It Really So Costly?","volume":"95","author":"Ovalle","year":"2016","journal-title":"Int J Radiat Oncol*Biol*Phys"},{"key":"10.1016\/j.ctro.2022.08.013_b0315","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.clon.2021.12.007","article-title":"Model-Based Selection for Proton Therapy for Breast Cancer: Development of the National Indication Protocol for Proton Therapy and First Clinical Experiences","volume":"34","author":"Boersma","year":"2022","journal-title":"Clin Oncol"},{"key":"10.1016\/j.ctro.2022.08.013_b0320","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2147\/BCTT.S109763","article-title":"Acute radiation dermatitis in breast cancer patients: challenges and solutions","volume":"9","author":"Kole","year":"2016","journal-title":"Breast Cancer Targets Ther"},{"issue":"6-7","key":"10.1016\/j.ctro.2022.08.013_b0325","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1080\/07357907.2021.1944180","article-title":"Geospatial Disparities in Access to Proton Therapy in the Continental United States","volume":"39","author":"Maillie","year":"2021","journal-title":"Cancer Invest"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630822000751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630822000751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:10:39Z","timestamp":1762503039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630822000751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":65,"alternative-id":["S2405630822000751"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2022.08.013","relation":{},"ISSN":["2405-6308"],"issn-type":[{"type":"print","value":"2405-6308"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes and toxicities after proton partial breast radiotherapy for early stage, hormone receptor positive breast cancer: 3-Year results of a phase II multi-center trial","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2022.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}]}}